Actively Recruiting
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Led by St. George's Hospital, London · Updated on 2026-05-08
26
Participants Needed
1
Research Sites
506 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Every week in the UK, 12 apparently healthy and fit individuals under the age of 35 die suddenly, a tragic event known as sudden cardiac death (SCD). The investigators have shown that heritable cardiac disorders affect the distribution of proteins at the cardiac cell-cell junctions, the areas where cardiac cells are mechanically and electrically coupled. This knowledge has helped the investigators diagnose specific heart disorders in individuals thus reducing the risk and incidence of SCD. Yet, the primary material required is a heart sample. A heart biopsy is an invasive process that comes with risks and is not performed unless absolutely necessary. And it is impossible to obtain a heart sample from an individual that may be carrying a disease-causing mutation (and hence be at risk of SCD) but does not yet show evidence of disease manifestation. The investigators recently showed that buccal cells show changes in protein distribution equivalent to those exhibited by the heart,hence providing them with a surrogate tissue for the myocardium. The investigators aim to use buccal smears as a means to identify those at risk of SCD. Patients regularly seen at the cardiology clinics at St. George's Hospital can participate in the study. The investigators shall take a buccal smear simply by rubbing a soft brush at the inside of their cheek and smearing it on a slide. Most individuals willing to participate in the study will only have to provide the investigators with a sample once. However, in selected cases (for instance, if the patients show disease progression or have a change in medication) they may be asked to provide the investigators with a subsequent sample during one of their scheduled follow-up visits. The process takes only a few seconds, is totally risk- and pain-free and it is anticipated to have great implications in diagnosis and patient management.
CONDITIONS
Official Title
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with heritable arrhythmic disorders including arrhythmogenic, hypertrophic and dilated cardiomyopathy, cardiac sarcoidosis, and cardiac channelopathies such as Long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia, followed at St. George's University Hospitals ICC service
- Family members of sudden cardiac death victims evaluated for risk and diagnosis, including those with disease manifestations and carriers of disease-causing mutations
- Individuals in the above groups regardless of their current management including medications, devices, or surgeries
- Individuals with co-existing medical conditions
- Adults aged over 18 years
- Pregnant women
- Individuals who provide signed informed consent
You will not qualify if you...
- Children under 18 years of age
- Individuals without decisional capacity
- Individuals with non-heritable, non-arrhythmic cardiac disorders such as ischemic heart disease or inflammatory heart conditions
- Non-English speakers without a translator available to explain the study and obtain informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St George'S Hospital
London, United Kingdom, SW17 0RE
Actively Recruiting
Research Team
A
Angeliki Asimaki
CONTACT
E
Elijah Behr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here